← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 1, 2008Last known activity
Nov 19, 2020
Acquired by Servier on Apr 7, 2020
Timeline
2000s
- Jun 1, 2000
Symphogen A/S— Founded
2020s
- Apr 7, 2020
Servier— Acquired By
Drugs by trial phase (15 distinct, 17 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (8 own, 0 via acquisition)
Indications
Recent trials (18)
- NCT04672434Lead sponsorPhase 1Nov 19, 2020
- NCT04641871Lead sponsorPhase 1Oct 12, 2020
- NCT03717038Lead sponsorPhase 3Feb 28, 2019
- NCT03549338Lead sponsorPhase 2Sep 30, 2018
- NCT03489343Lead sponsorPhase 1May 30, 2018
- NCT03489369Lead sponsorPhase 1May 8, 2018
- NCT03311412Lead sponsorPhase 1Dec 7, 2017
- NCT02965417Lead sponsorPhase 2Dec 1, 2016
- NCT02924233Lead sponsorPhase 1/Phase 2Nov 1, 2016
- NCT02906670Lead sponsorPhase 1/Phase 2Oct 1, 2016
- NCT02648724Lead sponsorPhase 1/Phase 2Mar 1, 2016
- NCT02568046Lead sponsorPhase 1/Phase 2Mar 1, 2016
- NCT02540161CollaboratorPhase 2Feb 1, 2016
- NCT02083653Lead sponsorPhase 2Mar 1, 2014
- NCT01417936Lead sponsorPhase 2Jul 1, 2011
Details
- Founded
- Lyngby, DK Jun 1, 2000
- Last known activity
- Nov 19, 2020